Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

A federal judge ended compounding pharmacies’ ability to make copies of the weight loss and diabetes drugs Zepbound and ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...